In bronchial epithelial and astrocytoma cell lines, CysLT1 antagonists can reduce PKA signalling following nucleotide stimulation of the P2Y1 purinergic receptor pathway. The gene discussed is P2RY1; the disease is astrocytoma (excluding glioblastoma).